Pregabalin Capsule
Product Images NDC 68788-8391

This is a description of a medication called Pregabalin, which is sold in 75mg capsules. The capsules are produced by Ascend Laboratories, LLC and are a generic version of the drug Lyrica. The package size and expiration date are not specified, but there are fields for the lot number, batch number and inscription. The medication must be kept in a controlled environment between 15-30°C. The capsules are orange and white, imprinted with "A009 PREG7S" and should be kept away from children. The directions are provided in English and indicate that the capsules should be taken at room temperature, at intervals specified by a doctor. A warning indicates that the medication should only be used by the person it was prescribed for, as per federal law. The rest of the text appears to be a chart log for billing purposes.*

This appears to be a formula for estimating creatinine clearance (CLCr) in female patients based on age, weight, and serum creatinine levels. However, without more context or information about the units, it is difficult to provide a more detailed description or analysis.*

This text appears to be a chart or table displaying results of different studies comparing the effectiveness of various doses of a medication versus a placebo. The medication was administered at varying doses (50mg/day, 150mg/day, 300mg/day, or 600mg/day). The results show the percentage change in a certain measurement (not specified) from the baseline value, as well as whether the change was statistically significant compared to the placebo group.*